Y a-t-il une place pour la médecine nucléaire dans la radioembolisation des tumeurs hépatiques ? [Is there a place for nuclear medicine in the radioembolization of liver tumors?]

0 avis

Y a-t-il une place pour la médecine nucléaire dans la radioembolisation des tumeurs hépatiques ? [Is there a place for nuclear medicine in the radioembolization of liver tumors?]

Archive ouverte

International audience. This is purposely an ultraprovocative title for the broad nuclear medicine community (including radiophysics and radiopharmacy) which leads us to ask questions about how we should correctly use 90Yttrium (MSY90) microspheres in the treatment of liver tumors.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Transarterial Radioembolization (TARE) Agents beyond Y-90-Microspheres

Archive ouverte | Bouvry, C. | CCSD

International audience. Liver malignancies, either primary tumours (mainly hepatocellular carcinoma and cholangiocarcinoma) or secondary hepatic metastases, are a major cause of death, with an increasing incidence. ...

Nuclear Medicine Therapy in primary liver cancers

Archive ouverte | Palard, X. | CCSD

International audience. Primary liver cancer, hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), are tumors of poor prognosis where treatment is frequently challenging, especially for inoperab...

99mTc-SSSlipiodol: mise au point du marquage et biodistribution après injection au niveau de l'artère hépatique du porc

Archive ouverte | Garin, E. | CCSD

National audience

Chargement des enrichissements...